Prolonged suppression of human immunodeficiency virus type 1 RNA during dual nucleoside reverse-transcriptase-inhibitor therapy in clinical practice.

Autor: Hoesley CJ; Division of Infectious Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294-2050, USA., Saag MS, Chatham A, Kilby JM
Jazyk: angličtina
Zdroj: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2000 Oct; Vol. 31 (4), pp. 1095-7.
DOI: 10.1086/318143
Abstrakt: Because there is limited information about suppression of virus loads (determined by current "ultrasensitive" assays) in patients receiving nucleoside reverse-transcriptase inhibitors (NRTIs) alone, we reviewed our experience in clinical practice with patients who had virus loads of <25 copies/mL after >1 year of treatment with dual NRTIs.
Databáze: MEDLINE